On July 23, 2015, Janssen Biotech, Inc. and New York University filed a brief appealing the rejection of all claims of U.S. Patent No. 6,284,471, a patent covering Remicade (infliximab),…
On July 23, 2015, Janssen Biotech, Inc. and New York University filed a brief appealing the rejection of all claims of U.S. Patent No. 6,284,471, a patent covering Remicade (infliximab),…
Abatacept (ORENCIA)+ U.S. Patent 8,476,239 Patent Owner: Bristol-Myers Squibb Title: Stable Protein Formulations IPR2015-01537, filed by Momenta Filing date: July 2, 2015 Status: Final…
Complaint Janssen Motion to Stay Janssen Motion for Partial Summary Judgment and PI Celltrion Hospira Answer and Defenses Celltrion Hospira Opposition to Motion to Stay Amended Joint Motion for…
Amgen appealed the district court order on March 25, 2015, and sought an expedited briefing schedule and an injunction to delay the launch of Sandoz’s Zarxio product while the Court…
District Court Litigation Amgen Complaint Sandoz Answer Amgen Answer to Counterclaims and Affirmative Defenses Amgen Motion for Partial Judgment on Pleadings Amgen Motion for…